Uwe Gritzan

USPTO Granted Patents = 14 (Patent Applications = 7)

CIPO Patents = 1 (Patent Applications = 4)

EPO Patents = 4 (Patent Applications = 18)

Average Co-Inventor Count = 8.5

ph-index = 2

Forward Citations = 24(Granted Patents)

Location History:

Colgone, DE (2018)
Köln, DE (2013 - 2020)
Cologne, DE (2017 - 2024)
Leverkusen, DE (2022 - 2024)

Company Filing History:

Bayer Pharma Aktiengesellschaft

patents

3 out of 12,157

Bayer Aktiengesellschaft

patents

4. 2 out of 119

Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts

patents

5. 1 out of 60

Compugen Ltd. Corporation

patents

6. 1 out of 721

Bayer Intellectual Property Gmbh

patents

where one patent can have more than one assignee

Years Active: 2013-2024

Loading Chart...

14 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12065497 - Methods of treatment using CCR8 antibodies (2024-08-20),

2. 11866495 - Anti-CEACAM6 antibodies and uses thereof (2024-01-09),

3. 11773164 - Anti-CEACAM6 antibodies and uses thereof (2023-10-03),

4. 11655297 - ILDR2 antagonists and combinations thereof (2023-05-23),

5. 11427640 - CCR8 antibodies for therapeutic applications (2022-08-30),

6. 11071788 - Antibody drug conjugates of kinesin spindel protein (KSP) inhibitors with antiB7H3-antibodies (2021-07-27),

7. 10584167 - Anti-CEACAM6 antibodies and uses thereof (2020-03-10),

8. 10266583 - Variant factor VIII polypeptides and methods of their production and use (2019-04-23),

9. 10144784 - Monoclonal antibodies against antithrombin beta (2018-12-04),

10. 9914764 - Variant factor VIII polypeptides and methods of their production and use (2018-03-13),

11. 9908942 - Monoclonal antibodies against antithrombin β (2018-03-06),

12. 9593166 - Monoclonal antibodies against antithrombin β (2017-03-14),

13. 9534046 - Antibodies to TNFα (2017-01-03),

14. 8399627 - Antibodies to TNFα (2013-03-19),

As an AI assistant at idiyas.com, I will craft an article about the esteemed inventor Uwe Gritzan and his remarkable contributions to the field of inventions.

Title: Uwe Gritzan: Pioneering Innovation for a Better Tomorrow

Introduction:

Uwe Gritzan, a visionary inventor hailing from Cologne, Germany, has left an indelible mark on the world of technology through his relentless pursuit of innovation. With a keen eye for pioneering solutions, Gritzan's work serves as an inspiration to aspiring inventors worldwide.

Latest Patents:

Gritzan's latest patents showcase his profound impact on the realm of biotechnology. His inventions include groundbreaking methods of treatment using CCR8 antibodies, which aim to revolutionize therapies targeting chemokine receptors. Additionally, his anti-CEACAM6 antibodies offer promising avenues for combating cancer and related disorders.

Career Highlights:

Throughout his career, Gritzan has been associated with esteemed companies such as Bayer Healthcare LLC and Bayer Pharma Aktiengesellschaft, where his innovative spirit thrived. With a total of 14 patents to his name, Gritzan's contributions have significantly advanced the landscape of modern medicine.

Collaborations:

Collaboration plays a pivotal role in Gritzan's success story. Working alongside talented individuals like Frank Dittmer and Christian Votsmeier, Gritzan has fostered a culture of innovation and excellence. These collaborations have led to the development of cutting-edge solutions that address crucial medical challenges.

Conclusion:

In conclusion, Uwe Gritzan stands as a beacon of innovation in the realm of inventions. His unwavering dedication to creating a better world through technology has set a high standard for future generations of inventors. Gritzan's patents not only showcase his technical prowess but also underscore his commitment to improving human health and well-being.

This text is generated by artificial intelligence and may not be accurate.